Inflammation News and Research

RSS

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases.

9 Dec 2016

Running can reduce joint inflammation, study finds

We all know that running causes a bit of inflammation and soreness, and that's just the price you pay for cardiovascular health. You know; no pain, no gain.

9 Dec 2016

Oral cavity bacterium linked to development and progression of esophageal cancer

A type of bacterium usually found in the human mouth, Fusobacterium nucleatum, has been found to be related to the prognosis of esophageal cancer in Japanese patients by researchers from Kumamoto University, Japan.

9 Dec 2016

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.

9 Dec 2016

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Psoriasis is well-known for causing too many skin cells on elbows, knees, and across the body, but people living with psoriasis may also be at an increased risk of heart disease.

9 Dec 2016

Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

Researchers cracked the complete genetic code of individual cells in healthy and diseased human lung tissues to find potential new molecular targets for diagnosing and treating the lethal lung disease Idiopathic Pulmonary Fibrosis (IPF).

8 Dec 2016

Researchers reveal key role of bacteria-binding protein in intestine

Deficiency in a certain protein in the gastrointestinal tract has been shown to lead to both inflammation and abdominal fat accumulation in mice.

8 Dec 2016

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of research findings today in the journal Science Translational Medicine.

7 Dec 2016

Changes in the pain and posture processing parts of the brain could cause whiplash symptoms

Study reveals changes in the regions of the brain connected to pain and posture processing.

7 Dec 2016

Obstructive sleep apnea can increase risk for PE recurrence

Pulmonary embolism (PE) is a major risk for patients suffering from venous thromboembolism (VTE) and can often be fatal.

7 Dec 2016

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

SUGAR-based adjuvants from Australia are boosting the effectiveness of vaccines to target some of the world’s deadliest diseases.

7 Dec 2016

Detecting inflammation in diabetic patients

As well as presenting with high blood glucose, diabetic patients have chronic low-grade inflammation, which can be measured by a range of inflammatory markers such as so-called high-sensitive CRP, TNFa and IL-6 as well as a full blood cell count.

7 Dec 2016

UCLA researchers discover how chronic inflammation increases prostate cancer risk

UCLA researchers have discovered a previously unrecognized type of progenitor cell that, though rare in most regions of the human prostate, is found in uncommonly high numbers in inflamed areas of the gland.

6 Dec 2016

Sedentary lifestyle may increase risk of environmentally induced lung disease

An inactive lifestyle may increase the risk of environmentally induced asthma symptoms.

6 Dec 2016

VIB scientists reveal how NLRP2 protein plays key role in early embryogenesis and fertility

Led by Prof. Mohamed Lamkanfi (VIB-Ghent University), researchers have demonstrated in animal models that a protein called NLRP2 plays an important role in early embryogenesis, the process of cell division in fertilized eggs that occurs before they implant into the lining of the uterus.

6 Dec 2016

Cedars-Sinai receives $7.3 million grant to test safety of novel cell-based therapy in treating PAH

Researchers from the Cedars-Sinai Heart Institute and the Cedars-Sinai Department of Medicine are expanding their ongoing evaluation of a novel cell-based therapeutic candidate into the area of pulmonary arterial hypertension (PAH).

6 Dec 2016

Researchers develop new microfluidic device to study brain inflammation

The blood-brain barrier is a network of specialized cells that surrounds the arteries and veins within the brain. It forms a unique gateway that both provides brain cells with the nutrients they require and protects them from potentially harmful compounds.

6 Dec 2016

Inflammation News and Research

Researchers discover new pathway that opens door to treat non-alcoholic fatty liver disease

Running can reduce joint inflammation, study finds

Oral cavity bacterium linked to development and progression of esophageal cancer

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

Studies show how overactive immune response may contribute to heart disease in psoriasis patients

Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

Researchers reveal key role of bacteria-binding protein in intestine

Investigational diabetes drug that impedes Parkinson's progression getting ready for human trials

Changes in the pain and posture processing parts of the brain could cause whiplash symptoms

Obstructive sleep apnea can increase risk for PE recurrence

Vaxine’s unique adjuvants boost effectiveness of vaccines for battling against infectious diseases

Detecting inflammation in diabetic patients

UCLA researchers discover how chronic inflammation increases prostate cancer risk

Sedentary lifestyle may increase risk of environmentally induced lung disease

VIB scientists reveal how NLRP2 protein plays key role in early embryogenesis and fertility

Cedars-Sinai receives $7.3 million grant to test safety of novel cell-based therapy in treating PAH

Researchers develop new microfluidic device to study brain inflammation

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Research unlocks potential new therapies for inflammatory diseases

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News